Evaluation and Management of BK Virus-Associated Nephropathy Following Allogeneic Hematopoietic Cell Transplantation

被引：12

作者：

Raval, Mihir ^{[2
]}

Gulbis, Alison ^{[3
]}

Bollard, Catherine ^{[4
]}

Leen, Ann ^{[4
]}

Chemaly, Roy ^{[5
]}

Shpall, Elizabeth ^{[1
]}

Lahoti, Amit ^{[6
]}

Kebriaei, Partow ^{[1
]}

机构：

[1] Univ Texas Houston, MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA

[2] Univ N Dakota, Dept Internal Med, Grand Forks, ND 58201 USA

[3] Univ Texas Houston, MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA

[4] Texas Childrens Hosp, Baylor Coll Med, Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA

[5] Univ Texas Houston, MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA

[6] Univ Texas Houston, MD Anderson Canc Ctr, Dept Nephrol, Houston, TX 77030 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 11期

关键词：

BK virus nephropathy; Hematopoietic cell transplantation; Antiviral therapy; BONE-MARROW-TRANSPLANTATION; ONSET HEMORRHAGIC CYSTITIS; POLYOMAVIRUS BK; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; NATIVE KIDNEYS; DONOR-TYPE; RECIPIENTS; LEFLUNOMIDE; INFECTION;

D O I：

10.1016/j.bbmt.2011.07.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BK virus nephropathy is a common cause of graft loss in kidney transplant recipients. Cases of BK nephropathy following allogeneic hematopoietic cell transplantation (HCT) are underreported. An increased incidence of BK virus-associated nephropathy is being seen in the setting of more profound and prolonged immunosuppression following solid organ transplantation and HCT. We will review diagnostic and treatment modalities for BK-associated nephropathy following allogeneic HCT. Biol Blood Marrow Transplant 17: 1589-1593 (2011) (C) 2011 American Society for Blood and Marrow Transplantation

引用

页码：1589 / 1593

页数：5